Tonghua Golden-Horse (000766.SZ): Amsacrine Succinate Tablets Included in National Medical Insurance Catalog

Zhitong Finance APP news, Tonghua Golden-Horse (000766.SZ) issued an announcement that the company's independently developed Class 1 chemical innovative drug, Anweyacridine Succinate Tablets, with completely independent intellectual property rights, has been included for the first time in the "National Drug Catalog for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance (2026)." The drug is used for the treatment of symptoms of mild to moderate Alzheimer's disease.